Dual blockade of LILRB1 and LILRB2 enhances antiviral immune responses in SIV infection
Florian Meurisse, Sixtine Coindre, Anne Wijkhuisen, Romain Marlin, Laure Fournier Le Ray, Juliette Pons, Melyssa Yaugel-Novoa, Véronique Avettand-Fènoël, Laurent Abi‐Rached, Anne-Sophie Gallouët, Francis Relouzat, Maël Gourvès, Asier Sáez‐Cirión, Hisashi Arase, Gérard Zurawski, , Benoı̂t Favier
This study shows that blocking LILRB1 and LILRB2 with a dual-specific antibody enhances antiviral immune responses in SIV infection without adverse effects.
Advanced Science · Jul 30, 2026Peer-reviewedImmunology